ImmunoGen, Inc. IMGN
31.24 +31.24
Day range unavailable
52-week range unavailable
News
globenewswire.com Antibody Drug Conjugates Market Size is Expected to Reach USD 25.38 Billion by 2033, Growing at a CAGR of 8.84%: Straits Research The global antibody drug conjugates market size was valued at USD 11.84 billion in 2024 and is projected to reach from USD 12.89 billion in 2025 to USD 25.38 billion by 2033, growing at a CAGR of…
investopedia.com AbbVie Cuts Its Guidance on ImmunoGen Deal Drug maker AbbVie (ABBV) is lowering its current quarter guidance because of costs related to its acquisition of ImmunoGen.
marketwatch.com AbbVie's stock dips premarket after it lowers Q1 guidance to reflect dilutive impact of ImmunoGen deal close AbbVie Inc.'s stock ABBV, -0.41% fell 0.5% early Monday, after the drug company lowered its first-quarter guidance to reflect the dilutive impact of its closure of the acquisition of ImmunoGen. The…
prnewswire.com AbbVie Completes Acquisition of ImmunoGen Adds flagship antibody-drug conjugate (ADC) ELAHERE® (mirvetuximab soravtansine-gynx) for folate receptor-alpha (FRα) positive platinum-resistant ovarian cancer (PROC) to AbbVie's portfolio…
zacks.com Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year? Here is how ImmunoGen (IMGN) and Achilles Therapeutics PLC Sponsored ADR (ACHL) have performed compared to their sector so far this year.
zacks.com ImmunoGen (IMGN) Soars 5.7%: Is Further Upside Left in the Stock? ImmunoGen (IMGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the…
investorplace.com 7 Russell 2000 Stocks to Buy for the Next Bull Run: February 2024 As 2023 wrapped up, Russell 2000 stocks, mirroring the dynamics of small-to-mid-cap companies, showed resilience, outperforming their initial stance. The iShares Russell 2000 ETF (NYSEARCA: IWM ), a…
businesswire.com ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
zacks.com How ImmunoGen (IMGN) Stock Stands Out in a Strong Industry ImmunoGen (IMGN) has seen solid earnings estimate revision activity over the past two month, and belongs to a strong industry as well.
cnbc.com Cramer names biopharma companies to watch as industry mergers start to pile up CNBC's Jim Cramer pointed out the numerous mergers and acquisitions across the biopharma industry.
zacks.com All You Need to Know About ImmunoGen (IMGN) Rating Upgrade to Strong Buy ImmunoGen (IMGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
zacks.com Best Momentum Stocks to Buy for January 4th IMGN and GTLB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 4, 2024.
zacks.com New Strong Buy Stocks for January 4th IMGN, GTLB, FNWD, BL and TMHC have been added to the Zacks Rank #1 (Strong Buy) List on January 4, 2024.
businesswire.com ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
benzinga.com Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.
fool.com AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why AbbVie needs to diversify its drug portfolio because of the loss of exclusive rights to Humira. The recent acquisition of ImmunoGen fills several needs and comes at an excellent time.
investorplace.com 3 Stocks at the Forefront of Medical Innovation Innovation in the medical world is undoubtedly a fundamental pillar in the development of humanity. There are great companies within the biotech sector doing wonderful work, research, and…
zacks.com 5 Reasons to be Bullish into 2024 2023: Predicting is Futile, Interpreting is Priceless
businesswire.com ImmunoGen Presents Findings from Newly Diagnosed Acute Myeloid Leukemia Cohorts in Phase 1b/2 Study of Pivekimab Sunirine in Combination with Azacitidine and Venetoclax at ASH WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Presents Findings from Newly Diagnosed AML Cohorts in Phase 1b/2 Study of Pivekimab Sunirine with Azacitidine and Venetoclax at ASH.
investorplace.com Market Movers: Why Big Players Are Investing Millions in These 3 Stocks Certain smart money stocks catch the discerning eye of big players in investing, drawing in substantial investments. Delving into the strategies and growth patterns of three companies reveals…
reuters.com Abbvie to focus on smaller deals after Cerevel and ImmunoGen buyout U.S. drugmaker Abbvie said on Thursday it does not expect any transactions similar to its $8.7 billion buyout of Cerevel Therapeutics in the foreseeable future and would instead focus on smaller…
benzinga.com Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.
benzinga.com Earnings Scheduled For November 2, 2023 Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023 
benzinga.com Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of…- benzinga.com Earnings Scheduled For July 31, 2023 Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million.
- benzinga.com Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.
- benzinga.com Eli Lilly, Livent, Super Micro Computer And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
benzinga.com Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 268% to $3.42 after dropping around 8% on Thursday.- benzinga.com Intel, Saia, Charter Communications And Other Big Stocks Moving Higher On Friday U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session.
- benzinga.com Earnings Scheduled For April 28, 2023 Companies Reporting Before The Bell • GrafTech International (NYSE:EAF) is likely to report quarterly loss at $0.01 per share on revenue of $123.00 million.
- benzinga.com Earnings Scheduled For March 1, 2023 Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
- benzinga.com HUYA, Tencent Music Entertainment, Taiwan Semiconductor Manufacturing, And Some Other Big Stocks Moving Higher In Today's Pre-Market Session U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
- benzinga.com Earnings Scheduled For November 4, 2022 Companies Reporting Before The Bell • Sprott (NYSE:SII) is likely to report quarterly earnings at $0.49 per share on revenue of $49.95 million. • Telefonica (NYSE:TEF) is likely to report earnings…
- benzinga.com Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know Editor's note: This story has been corrected to reflect that the FDA deferred action on Amicus Therapeutics' Biologics License Application.
- benzinga.com Earnings Scheduled For July 29, 2022 Companies Reporting Before The Bell • Capital Product Partners (NASDAQ:CPLP) is expected to report quarterly earnings at $1.13 per share on revenue of $72.73 million.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 951 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's trading, 1214 companies set new 52-week lows.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 807 companies reached new 52-week lows.- benzinga.com Earnings Scheduled For May 6, 2022 Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEP) is expected to report quarterly loss at $0.02 per share on revenue of $1.27 billion.
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers
benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's session, 39 stocks hit new 52-week lows.- benzinga.com Earnings Scheduled For February 25, 2022 Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2021 - benzinga.com Earnings Scheduled For July 30, 2021 Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its second quarter.
- benzinga.com Earnings Scheduled For May 10, 2021 Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report earnings for its first quarter.
- benzinga.com 52 Weeks High Article 0.004831689889895241 Stocks That Hit 52-Week Highs On Friday Before 10 a.m. ET on Friday, 202 companies set new 52-week highs.
- benzinga.com Stocks Making New 52-Week Highs/Lows For Monday, Feb. 8, 2021 (Via Benzinga Pro's Signals Tool) Highs: KB Home (KBH) Sientra (SIEN) Moderna (MRNA) Veritone (VERI) Marathon Patent Group (MARA) Neogen (NEOG) Toll Brothers (TOL) Veru (VERU) Teledoc Health (TDOC) Foot Locker (FL) Esports…